CILENTRA 20 ESCITALOPRAM OXALATE TABLET USP 20MG
Product details
Registration number: SIN17139P
Classification: Prescription Only
Active ingredients: Escitalopram Oxalate eqv Escitalopram
Strength: 20mg
Dosage form: TABLET, FILM COATED
Route: ORAL
Registrant: RANBAXY (MALAYSIA) SDN. BHD.
ATC code: N06AB10
HSA approval date: 15 November 2024
Manufacturer(s): SUN PHARMACEUTICAL INDUSTRIES LIMITED
Manufacturing country/countries: INDIA
What are the HSA registration number and classification for CILENTRA 20 ESCITALOPRAM OXALATE TABLET USP 20MG?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN17139P
Classification: Prescription Only
What active ingredients and strength are recorded for CILENTRA 20 ESCITALOPRAM OXALATE TABLET USP 20MG?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Escitalopram Oxalate eqv Escitalopram
Strength: 20mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for CILENTRA 20 ESCITALOPRAM OXALATE TABLET USP 20MG?
According to the HSA dataset updated 7 August 2026:
Dosage form: TABLET, FILM COATED
Route: ORAL
Who is the recorded registrant for CILENTRA 20 ESCITALOPRAM OXALATE TABLET USP 20MG?
According to the HSA dataset updated 7 August 2026:
Registrant: RANBAXY (MALAYSIA) SDN. BHD.
Which manufacturers and countries are listed for CILENTRA 20 ESCITALOPRAM OXALATE TABLET USP 20MG?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): SUN PHARMACEUTICAL INDUSTRIES LIMITED
Manufacturing country/countries: INDIA
Where can I look up CILENTRA 20 ESCITALOPRAM OXALATE TABLET USP 20MG in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN17139P or the exact product name CILENTRA 20 ESCITALOPRAM OXALATE TABLET USP 20MG. The general register link does not preselect this product.
What are the source dates for this CILENTRA 20 ESCITALOPRAM OXALATE TABLET USP 20MG record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this CILENTRA 20 ESCITALOPRAM OXALATE TABLET USP 20MG record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN17139P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)